# Progress Note 06 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Srinivasa Ramanujan (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET020-SYN-TD
- Date: 1917-04-06
- Fictional facility: St. Posthumous Health Center
- Fictional author: Edmund Ashworth, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Preventive Visit
- Services: CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Periodic adult preventive visit, with advice before a summer visit to his family in India. **S**

## History of present illness

Mr. Ramanujan is a 29-year-old mathematician who comes for a preventive visit three weeks after a cold, which settled in four days. He finished treatment for an amebic liver abscess two months ago and has completed six weeks of rifampin for latent tuberculosis infection, with no missed doses and no side effects. He is eating twice a day now, with dal, curd rice and vegetables cooked in batches, and has regained most of the weight he lost. He goes to counseling weekly, calls home each Sunday, and has had a meal most weeks with families from the local Tamil association. He plans to visit his wife and family in South India for six weeks in the summer and asked what he needs before he goes. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 29 |
| Travel | Six weeks with family in South India this summer |
| Rifampin | Six weeks of four months; no side effects |
| Mood | PHQ-9 6 |

## Health risk assessment

Completed on paper in the waiting room and reviewed with him by Dr. Ashworth. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good and improving |
| Psychosocial | Less alone: weekly calls home, counseling, and meals with the Tamil association; work going well again |
| Substance use | No tobacco, alcohol or drugs (AUDIT-C 0) |
| Physical activity | Walks to the department and around the town most days |
| Nutrition | Two cooked meals a day within his vegetarian rules; milk and curd daily; vitamin B12 and vitamin D tablets |
| Sleep | Seven hours on most nights; still works late sometimes |
| Food and housing | Secure; a shared kitchen he can use at hours that suit his cooking |
| Safety | Feels safe; no firearm |
| Sexual health | Married; monogamous |
| Activities of daily living | Independent |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or night sweats; weight up 4 kg since January |
| Eyes | Negative | Orange tears on rifampin; no change in vision |
| Ears, nose, mouth, and throat | Negative | Cold resolved |
| Cardiovascular | Negative | No chest pain or palpitations |
| Respiratory | Negative | No cough |
| Gastrointestinal | Negative | No abdominal pain or diarrhea |
| Genitourinary | Negative | Orange urine on rifampin; no burning |
| Musculoskeletal | Negative | No joint pain |
| Integumentary | Negative | No rash |
| Neurological | Negative | No numbness or tingling |
| Psychiatric | Negative | Mood better; no thoughts of self-harm |

11 systems reviewed. **S**

## Current medications

- Vitamin B12 (cyanocobalamin) 1,000 microgram oral tablet, one tablet daily **S**
- Cholecalciferol 2,000 unit (50 microgram) oral tablet, one tablet daily, from the end of the weekly course **S**
- Rifampin 300 mg oral capsule, two capsules (600 mg) once daily on an empty stomach for 4 months **S**

## Allergies

- No known allergy **S**

## Objective

BP 116/72 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 56 kg; BMI 20.6 kg/m². All vital signs are synthetic.

PHQ-9: 6; AUDIT-C: 0. All results are synthetic.

## Change since baseline

- PHQ-9: 12 at baseline, 6 at this visit **S**

## Immunizations given today

- Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) **S**
- Hepatitis B vaccine (HepB-CpG), dose 1 of 2 **S**
- Typhoid Vi capsular polysaccharide vaccine, injectable **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; weight 56.0 kg, BMI 20.6; blood pressure 116/72 |
| Eyes | Sclerae white |
| Mouth | Teeth and gums healthy |
| Neck | No nodes or thyroid enlargement |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear |
| Abdomen | Soft; liver not tender or enlarged |
| Skin | No rash or jaundice |
| Neurological | Vibration and position sense normal in the feet |
| Psychiatric | Brighter; engaged |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan updated. HIV and hepatitis C tests at intake were negative, and hepatitis B screening showed no infection and no immunity. Hepatitis A antibody sent today; he is likely immune from childhood, and the vaccine will be given before travel if not. Before his trip: the injectable typhoid vaccine, because the oral live vaccine should not be given with rifampin; food and water precautions; and the malaria risk for his destination to be checked with the travel clinic. Tdap and the first hepatitis B dose given with his agreement. HPV vaccination was discussed, as shared decision-making applies from 27 to 45; he declined. **S**
   - Second hepatitis B dose in one month or more.
   - Travel clinic for malaria advice before he goes.
   - Enough rifampin for the trip, so that the course is completed without a break.
   - Dentist through the student dental service.
   - Next preventive visit in one year.
2. **Latent tuberculosis infection on rifampin** (Z22.7). Six weeks of four months: no side effects; adherent. Monthly clinical check done today. **S**
   - Continue rifampin; finish the course during or before the trip.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 116/72 mmHg |
| Depression screening | Completed today | PHQ-9 6; under treatment for an adjustment disorder |
| Unhealthy alcohol use screening | Completed today | AUDIT-C 0 |
| Tobacco use | Completed today | Never |
| HIV screening | Up to date | Negative at intake |
| Hepatitis C screening | Up to date | Negative at intake |
| Hepatitis B screening | Up to date | Surface antigen and core antibody negative at intake; no immunity |
| Tuberculosis testing | Up to date | IGRA positive at intake; active disease excluded; latent infection under treatment |
| Diabetes screening | Up to date | A1c 5.4% at intake; South Asian ancestry noted for future screening even at a lower BMI |
| Lipid screening | Due | Not yet measured; at the next routine blood draw |
| Tdap | Completed today | No booster within ten years |
| Hepatitis B vaccine | Completed today | Dose 1 of 2 (HepB-CpG) |
| Typhoid vaccine before travel | Completed today | Injectable Vi polysaccharide vaccine at least two weeks before travel; the oral live vaccine avoided on rifampin |
| Hepatitis A immunity before travel | Ordered | Antibody sent today; vaccine before travel if not immune |
| Influenza vaccine | Up to date | Given in February |
| COVID-19 vaccine | Due | In the autumn |
| HPV vaccine | Declined | Shared decision from 27 to 45; he declined |
| Dental examination | Due | Student dental service |

## Advance care planning

Voluntary advance care planning discussion of about 15 minutes, with his consent. He wants full treatment of any illness that could be reversed, and wants his family in India told if he is seriously ill. He asked that his religious practices and vegetarian diet be respected if he is ever in hospital, and that was recorded. He named a health care agent, recorded in the confidential part of the chart and not named here, and chose not to record other treatment preferences today. To be revisited yearly or after any serious illness. **S**

## Guideline basis

- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Hepatitis C Virus Infection in Adolescents and Adults: Screening (2020), U.S. Preventive Services Task Force
- Human Immunodeficiency Virus (HIV) Infection: Screening (2019), U.S. Preventive Services Task Force
- Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018), U.S. Preventive Services Task Force
- Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations, United States, 2023 (2023), Centers for Disease Control and Prevention (MMWR Recomm Rep 2023)
- Typhoid and Paratyphoid Fever (CDC Yellow Book) (2026), Centers for Disease Control and Prevention

## Follow-up

- Travel clinic before the trip; second hepatitis B dose in a month or more. Three-month review in two weeks with blood count, liver tests, vitamins and mood. Next preventive visit in one year. **S**
- Next scheduled visit 1917-04-20: three months: abscess treatment complete, rifampin month two, blood count, liver tests, vitamins, mood, and plans to visit home. **S**
